| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8784853 | Advances in Radiation Oncology | 2018 | 29 Pages |
Abstract
Compared with clinical planning methods, optimized 4Ï radiation therapy enables statistically significant sparing of the cochleae in acoustic neuroma treatment as well as lowering of other OAR doses, potentially reducing the risk of hearing loss.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kaley MS, Percy MD, Tania MD, Isaac MD, Ke PhD,